Founding Partner & Head, Research and Product
Vidya helped build one of the country’s earliest robo-advisory solutions in the country in her earlier role at FundsIndia. She believes in not just providing the right solutions for investors but also taking ownership for the same and following up or changing course when the situation warrants.
Vidya was the head of mutual fund research at FundsIndia where she did some path-breaking work in analysing funds and offering researched portfolios. Her recommendations had a sound track record of beating markets and showcasing consistency. They were followed widely by investors, advisors and media.
A Chartered Accountant by qualification, Vidya began her career as a Senior Internal Auditor for Ashok Leyland. She then went on to work for The Hindu Business Line’s Research Bureau, tracking mutual funds, stock markets, sectors and the macro economy for eight years. She has more than 18 years of experience, of which over 15 were spent analyzing the markets.
Vidya is known in the media for her straight talk and, calling out bad products.
Stay in touch
Vidya in the media
Watch Vidya talk about her financial journey
Vidya's recent articles
We are asking you to book profits on this Prime Stock that was an underperformer for a while but has quickly delivered returns.
In 2023, one didn’t have to do much for their investments to have made decent returns at the end but 2024 promises to be different. Vidya Bala tells you how to navigate.
Lofty return expectations can set you up for some rude shocks! Find out how to set your return expectations right in this article.
Some sectors like financial services face a lot of risks from external factors but we have a financial stock where we think the reward is commensurate with the risk and so we are issuing a BUY call.
We are adding this secured, listed NCD with attractive yields that compensate for the risk which is also mitigated by other factors.
While this sector is currently in a consolidation zone, it’s a good time to begin loading up as factors for a recovery are starting to line up.